4//SEC Filing
GORMAN KEVIN CHARLES 4
Accession 0000914475-25-000137
CIK 0000914475other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 6:15 PM ET
Size
5.3 KB
Accession
0000914475-25-000137
Insider Transaction Report
Form 4
GORMAN KEVIN CHARLES
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-05-27$120.38/sh−9,613$1,157,211→ 514,596 total
Footnotes (3)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2025.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $119.62 to $120.87. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]514,596 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001201096
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 6:15 PM ET
- Size
- 5.3 KB